OQROGet OQRO Pro
Insider trade

Biocardia (BCDA)Director bought ~$200K

Simon H Stertzer, Director at Biocardia, bought ~$200K of Biocardia shares.

~$200K
Approx. value · 105K sh @ $1.91
120K
Holds after · shares reported
Traded
Apr 23, 2025
Filed
Apr 26, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 3, 2025Insider · 2 peopleInsiders: 2 purchases (~$53K)
  2. Mar 4, 2025InsiderDirector purchased ~$36K of BCDA shares in the open market
  3. Mar 5, 2025InsiderDirector purchased ~$2.5K of BCDA shares in the open market
  4. Apr 2, 2025InsiderCEO purchased ~$1.1K of BCDA shares in the open market
  5. Apr 3, 2025Insider · 1 personInsiders: 2 purchases (~$4K)
  6. Apr 4, 2025InsiderCEO purchased ~$1.6K of BCDA shares in the open market
  7. Apr 7, 2025InsiderCEO purchased ~$980 of BCDA shares in the open market
  8. Apr 10, 2025InsiderCEO purchased ~$597 of BCDA shares in the open market
  9. Apr 11, 2025InsiderCEO purchased ~$609 of BCDA shares in the open market
  10. Apr 15, 2025InsiderCEO purchased ~$214 of BCDA shares in the open market
  11. Apr 23, 2025 · this disclosureInsiderDirector purchased ~$200K of BCDA shares in the open market

What came next

  1. Apr 23, 2025Insider · 5 peopleInsiders: 5 purchases (~$375K)
  2. May 14, 2025InsiderCEO purchased ~$299 of BCDA shares in the open market
  3. May 16, 2025InsiderCEO purchased ~$730 of BCDA shares in the open market
  4. May 20, 2025InsiderCEO purchased ~$3.3K of BCDA shares in the open market
  5. May 22, 2025InsiderCEO purchased ~$1.3K of BCDA shares in the open market
  6. May 30, 2025InsiderCEO purchased ~$221 of BCDA shares in the open market
  7. Jun 30, 2025Insider · 4 peopleInsiders: 4 purchases (~$360K)
  8. Aug 11, 2025InsiderCEO purchased ~$3K of BCDA shares in the open market
  9. Aug 12, 2025InsiderCEO purchased ~$700 of BCDA shares in the open market
  10. Aug 13, 2025InsiderCEO purchased ~$183 of BCDA shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Biocardia

For Biocardia, OQRO holds 9 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BCDA page.

Other recent filings by Simon H Stertzer, Director

The full history of Simon H Stertzer, Director is on the profile page.

How this filing works

Other disclosures at Biocardia

Everything OQRO holds on this company is on its BCDA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data